These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34627705)

  • 1. Prognostic factors in patients hospitalized with community-acquired aspiration pneumonia.
    Seo H; Cha SI; Lee WK; Park JE; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
    J Infect Chemother; 2022 Jan; 28(1):47-53. PubMed ID: 34627705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of N-Terminal Prohormone of Brain Natriuretic Peptide on Patients Hospitalized with Community-Acquired Pneumonia.
    Seo H; Cha SI; Shin KM; Lim JK; Choi SH; Lee YH; Yoo SS; Lee SY; Lee J; Kim CH; Park JY
    Am J Med Sci; 2020 Oct; 360(4):383-391. PubMed ID: 32690276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
    Chen Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimarker Prognostication for Hospitalized Patients with Community-acquired Pneumonia.
    Yeon Lee S; Cha SI; Seo H; Oh S; Choi KJ; Yoo SS; Lee J; Lee SY; Kim CH; Park JY
    Intern Med; 2016; 55(8):887-93. PubMed ID: 27086800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia.
    Nowak A; Breidthardt T; Christ-Crain M; Bingisser R; Meune C; Tanglay Y; Heinisch C; Reiter M; Drexler B; Arenja N; Twerenbold R; Stolz D; Tamm M; Müller B; Müller C
    Chest; 2012 Apr; 141(4):974-982. PubMed ID: 22135381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of aspiration pneumonia compared with non-aspiration pneumonia: a retrospective cohort study.
    Hayashi M; Iwasaki T; Yamazaki Y; Takayasu H; Tateno H; Tazawa S; Kato E; Wakabayashi A; Yamaguchi F; Tsuchiya Y; Yamashita J; Takeda N; Matsukura S; Kokubu F
    J Infect Chemother; 2014 Jul; 20(7):436-42. PubMed ID: 24834866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?
    Akpınar EE; Hoşgün D; Akpınar S; Ateş C; Baha A; Gülensoy ES; Ogan N
    J Bras Pneumol; 2019 Aug; 45(4):e20180417. PubMed ID: 31411279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Timing of sequential noninvasive mechanical ventilation following early extubation in aged patients with severe community-acquired pneumonia].
    Jia W; Wan Q; Xu S; Yang T; Shi Y; Luo X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Mar; 32(3):324-329. PubMed ID: 32385997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the severity and prognosis assessment of aged patients with community-acquired pneumonia: a retrospective study.
    Xiao K; Su LX; Han BC; Yan P; Yuan N; Deng J; Li J; Xie LX
    J Thorac Dis; 2013 Oct; 5(5):626-33. PubMed ID: 24255776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.
    España PP; Capelastegui A; Quintana JM; Bilbao A; Diez R; Pascual S; Esteban C; Zalacaín R; Menendez R; Torres A
    J Infect; 2010 Feb; 60(2):106-13. PubMed ID: 19961875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Lysophosphatidylcholine for Determining the Disease Severity and Prognosis of Elderly Patients with Community-Acquired Pneumonia.
    Gu M; Lv S; Song Y; Wang H; Zhang X; Liu J; Liu D; Han X; Liu X
    Clin Interv Aging; 2024; 19():517-527. PubMed ID: 38528884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application and comparison of scoring indices to predict outcomes in patients with healthcare-associated pneumonia.
    Fang WF; Yang KY; Wu CL; Yu CJ; Chen CW; Tu CY; Lin MC
    Crit Care; 2011; 15(1):R32. PubMed ID: 21247444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
    Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z
    Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia.
    Falcone M; Corrao S; Venditti M; Serra P; Licata G
    Intern Emerg Med; 2011 Oct; 6(5):431-6. PubMed ID: 21249471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission lysophosphatidylethanolamine acyltransferase level predicts the severity and prognosis of community-acquired pneumonia.
    Chen L; Zhao L; Shang Y; Xu Y; Gao Z
    Infection; 2021 Oct; 49(5):877-888. PubMed ID: 33694084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia].
    Chen L; Han XD; Li YL; Zhang CX; Xing XQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Mar; 48(3):228-235. PubMed ID: 32234181
    [No Abstract]   [Full Text] [Related]  

  • 19. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study.
    Lazar Neto F; Marino LO; Torres A; Cilloniz C; Meirelles Marchini JF; Garcia de Alencar JC; Palomeque A; Albacar N; Brandão Neto RA; Souza HP; Ranzani OT; ; ; ;
    Clin Microbiol Infect; 2021 Jul; 27(7):1037.e1-1037.e8. PubMed ID: 33813111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded A-DROP Score: A New Scoring System for the Prediction of Mortality in Hospitalized Patients with Community-acquired Pneumonia.
    Ahn JH; Choi EY
    Sci Rep; 2018 Oct; 8(1):14588. PubMed ID: 30275523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.